This website places cookies on your device to help us improve our service to you. To find out more about the cookies, see our Privacy and Cookies notice
ISD Scotland better information, better decisions, better health

Scottish Clinical Trials Research Unit

Products and Services

NHS National Services Scotland ISD Scotland & NHS National Services Scotland

Studies - Completed


Gemcitabine and Radiotherapy in Non-Small Cell Lung Cancer.

A Phase III study of radical radiotherapy with or without Gemcitabine in patients with T1-2 N0-1 Non-Small Cell Lung Cancer.

Chief Investigator: Professor Allan Price

Main Sponsor: University of Edinburgh

Trial Coordinating Centre:
Cancer Clinical Trials Unit,
Gyle Square,
1 South Gyle Crescent,
EH12 9EB

Funder: Eli Lilly and Company Ltd

Recruitment: 111 participants between 2003 and 2005


Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer. - PubMed - NCBI

Price, Allan; Yellowlees, Ann; Faivre-Finn, Corinne; Gilligan, David; Snee, Michael; Erridge, Sara; Mohammed, Nazia; Russell, Susan / A randomised trial of radical radiotherapy with or without low dose gemcitabine in medically inoperable patients with T1-2 N0-1 M0 non-small cell lung cancer (NSCLC).
In: Journal of Thoracic Oncology, Vol. 4, No. 9, 09.2009, p. S587-S587.


© ISD Scotland 2010
Information Services Division,
NHS National Services Scotland,
Gyle Square,
1 South Gyle Crescent,
Edinburgh EH12 9EB,
Tel: 0131 275 7050  
Contact Us

About Information Services Division | Contact Us | Accessibility | Complaints
Copyright | Terms and Conditions | Privacy | Freedom of Information

ISD is a division of NHS NSS
Working at the very heart of the health service, NSS delivers services critical to frontline patient care and in support of the efficient and effective operation of NHS Scotland. Visit the NSS Website for more information